Loading provider…
Loading provider…
Neurology Physician in Philadelphia, PA
NPI: 1003074584Primary Practice Location
PENNSYLVANIA HOSPITAL
800 Spruce St, Philadelphia, PA
Primary Employer
Perelman Center for Advanced Medicine
pennmedicine.org
HQ Phone
Get MD Meredith's Phone Numberphone_androidMobile
Get MD Meredith's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 287 | 380 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 139 | 152 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 82 | 91 |
| 4 | 95970Electronic analysis of implanted brain spinal cord or peripheral neurostimulator generator system | 60 | 77 |
| 5 | 95983Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | 58 | 155 |
Authors: Andrew Siderowf, David Irwin, Lauren Elman, David Wolk
Journal: Acta Neuropathol
Publication Date: 2020-08-17
Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias.
Authors: David Irwin, Daniel Weintraub, David Wolk
Journal: Parkinsonism Relat Disord
Publication Date: 2022-08-06
Global Perspective on Telemedicine for Parkinson's Disease.
Authors: Shalash, Ali, Spindler, Meredith, Cubo, Esther
Journal: J Parkinsons Dis
Lead Sponsor: University of Rochester
Collaborators: Biogen, Takeda
Lead Sponsor: Takeda
Collaborators: Michael J. Fox Foundation for Parkinson's Research
Intervention / Treatment: DRUG: Placebo, DRUG: TAK-071
Lead Sponsor: Northwestern University
Collaborators: Michael J. Fox Foundation for Parkinson's Research, University of Rochester, University of Iowa
Intervention / Treatment: DRUG: Placebo, DRUG: Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), DRUG: Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)